Container Closure Integrity Testing (CCIT) is an important component of quality control that measures whether container closure systems can provide an effective barrier toward contaminants which, for example, comprise microorganisms and some volatile reactive materials. This is critical in assuring the quality and safety of pharmaceutical, biological, and vaccine products during their shelf life.
Regulatory Guidelines for Container Closure Integrity
The integrity of the product CCIT is ensured by appropriate regulatory standards defined by:
Methods of CCIT
The methods for CCIT can be divided into broad two categories of primary and secondary approaches, with preference given to the accuracy and dependability of deterministic methods over probability ones.
Deterministic Methods (Preferred):
These methods are the preferred choice due to their accuracy and reliability.
Probabilistic Methods (Less Reliable)
Pharmaceutical Packaging Standards and Testing
To avoid a pharmaceutical product’s exposure to moisture, oxygen, heat, or even UV light, the industry implements tough packaging regulations to ensure that contamination and degradation do not occur.
- USP 661: Describes what is needed for packaging materials.
- USP 661.1: Deals with constructing plastic materials.
- USP 661.2: Covers the assessment of the entire packaging system to determine if it is complete and safe.
Testing for Packaging Materials Initial Methods:
Reasons To Opt for Chromak Research
Container closure integrity testing services are best managed by Chromak Research, where clients get:
- ISO 17025:2017 Certification: Verification of international quality compliance.
- Registered with FDA & cGMP Services: Satisfying requirements for drug and biologics packaging.
- Expert team: Numerous years in formulating detailed test scopes for various container systems.
- Modern Technology: The newest methods of testing container systems for integrity, including deterministic CCIT, are now available.
- Regulatory Compliance: Services for compliance with USP, CFR, and European Pharmacopeia are provided.
In order to assure the sterility of the contents and the integrity of the pharmaceutical packaging, analysis by CCIT is cooperative. Complying with guidelines, monitoring and implementing sophisticated testing methodologies assures the safety and efficacy of the product. Chromak Research Team includes specialized CCIT service provisions compliant with FDA and GMP requirements. Reach out today for closure integrity testing services or help navigate your specific packaging needs.